Please login to the form below

Not currently logged in
Email:
Password:

PsiOxus Therapeutics

This page shows the latest PsiOxus Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Bristol-Myers Squibb acquires Cormorant for $520m

Bristol-Myers Squibb acquires Cormorant for $520m

That project will look at the safety and efficacy of enadenotucirev - which is made by PsiOxus Therapeutics in Oxford, UK - in combination with Opdivo for the treatment of a range of

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    995+. PsiOxus Therapeutics (UK). BMS (US). Licence. NG-348: preclinical “ armed” oncolytic virus targeting tumour cells. ... and Bicycle Therapeutics at $1bn, and the Purdue Pharma-Exicure deal, at $790m.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Crescendo Biologics appoints CFO Crescendo Biologics appoints CFO

    She joins from PsiOxus Therapeutics where she served as chief financial officer, and has also held a number of positions at Cytomyx Holdings, OrthoMimetics, and Mission Therapeutics. ... ambitious plans to create a high value pipeline of differentiated

  • Paolo Paoletti named as executive chairman of Kesios Paolo Paoletti named as executive chairman of Kesios

    Imperial Innovations Group has appointed Dr Paolo Paoletti as executive chairman of portfolio company Kesios Therapeutics. ... Paoletti is additionally a non-executive director of PsiOxus Therapeutics, Innovation's sixth largest portfolio company, which

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics